NCT07284446 · RECRUITING

Depressive Symptoms, Cognitive Impairment, and Outcomes in Hospitalized Chronic Heart Failure Patients

This observational study is tracking hospitalized chronic heart failure patients to see whether depression and mild cognitive impairment make their outcomes worse. Researchers will have participants fill out surveys measuring mood and thinking ability during their hospital stay. It is not a treatment trial — no drug or intervention is being tested. Because the phase is unspecified and no intervention is involved, this is a data-gathering study, not a test of something new.

You may qualify if

  • patient hospitalized primarily for CHF exacerbation;
  • clinically stable, able to provide informed consent;
  • do not have severe cognitive impairment that would preclude valid questionnaire administration.

You're excluded if

  • hospitalization for acute heart failure;
  • total length of hospital stay \<96 hours;
  • absence of transthoracic echocardiography (TTE) within the last 12 months and no TTE planned;
  • severe visual impairment preventing completion of the visual part of the Montreal Cognitive Assessment;
  • refusal to participate.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-12-16

View full record on ClinicalTrials.gov

All APOE4 clinical trials